PAMELA DUGANO - DAPHNIS: Open Payments
NPI 1982695037 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 97 payments from 15 companies in 2025. Trend: 2023 $2,487 · 2024 $2,057 · 2025 $2,096
Food & beverage: $2,096
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 36 | $804 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $391 |
| GlaxoSmithKline, LLC. | 12 | $256 |
| Amgen Inc. | 15 | $227 |
| Indivior Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $52 |
| Corcept Therapeutics | 2 | $45 |
| Novo Nordisk Inc | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 2 | $34 |
Products named: FARXIGA, Kerendia, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, SUBLOCADE, MOUNJARO, BREZTRI.
Industry payments across TX — which companies pay providers there.
